COPT Defense Properties (NYSE:CDP) Given “Overweight” Rating at Cantor Fitzgerald

COPT Defense Properties (NYSE:CDP)‘s stock had its “overweight” rating reiterated by investment analysts at Cantor Fitzgerald in a note issued to investors on Thursday,Benzinga reports. They currently have a $37.00 price objective on the stock. Cantor Fitzgerald’s target price would suggest a potential upside of 5.58% from the company’s previous close.

Several other analysts have also recently weighed in on CDP. Weiss Ratings raised COPT Defense Properties from a “buy (b-)” rating to a “buy (b)” rating in a report on Tuesday, April 21st. Wells Fargo & Company increased their target price on COPT Defense Properties from $35.00 to $36.00 and gave the stock an “overweight” rating in a research note on Monday, June 1st. Evercore reaffirmed an “outperform” rating and issued a $38.00 target price on shares of COPT Defense Properties in a research report on Tuesday, April 28th. Truist Financial increased their price target on COPT Defense Properties from $33.00 to $34.00 and gave the company a “hold” rating in a research report on Monday, June 8th. Finally, JPMorgan Chase & Co. increased their price objective on COPT Defense Properties from $33.00 to $34.00 and gave the company a “neutral” rating in a report on Friday, May 15th. Five research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $35.00.

COPT Defense Properties Trading Up 0.2%

Shares of CDP stock opened at $35.05 on Thursday. The company has a market capitalization of $3.97 billion, a P/E ratio of 25.39 and a beta of 0.79. COPT Defense Properties has a 12-month low of $26.91 and a 12-month high of $35.10. The firm has a 50-day moving average price of $32.47 and a 200 day moving average price of $31.27. The company has a quick ratio of 2.85, a current ratio of 2.85 and a debt-to-equity ratio of 1.63.

COPT Defense Properties (NYSE:CDP) last issued its quarterly earnings data on Monday, April 27th. The company reported $0.34 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.68 by ($0.34). COPT Defense Properties had a net margin of 20.10% and a return on equity of 10.02%. The business had revenue of $200.64 million during the quarter, compared to the consensus estimate of $185.10 million. During the same quarter in the previous year, the firm posted $0.65 EPS. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. COPT Defense Properties has set its FY 2026 guidance at 2.730-2.790 EPS and its Q2 2026 guidance at 0.680-0.700 EPS. Research analysts forecast that COPT Defense Properties will post 2.78 earnings per share for the current fiscal year.

Insider Transactions at COPT Defense Properties

In related news, Director Robert L. Denton sold 3,922 shares of COPT Defense Properties stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $32.38, for a total value of $126,994.36. Following the transaction, the director directly owned 3,803 shares of the company’s stock, valued at $123,141.14. This trade represents a 50.77% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.66% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. increased its holdings in shares of COPT Defense Properties by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 17,127,858 shares of the company’s stock worth $476,154,000 after buying an additional 128,583 shares in the last quarter. Alliancebernstein L.P. boosted its stake in shares of COPT Defense Properties by 16.8% in the 3rd quarter. Alliancebernstein L.P. now owns 8,457,373 shares of the company’s stock valued at $245,771,000 after purchasing an additional 1,215,936 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in COPT Defense Properties by 8.3% during the 4th quarter. JPMorgan Chase & Co. now owns 3,862,294 shares of the company’s stock worth $107,372,000 after acquiring an additional 296,221 shares during the period. Geode Capital Management LLC grew its stake in COPT Defense Properties by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 3,149,130 shares of the company’s stock worth $87,558,000 after purchasing an additional 17,049 shares during the period. Finally, Bank of America Corp DE lifted its position in shares of COPT Defense Properties by 5.4% during the 2nd quarter. Bank of America Corp DE now owns 2,577,065 shares of the company’s stock valued at $71,075,000 after acquiring an additional 131,287 shares during the period.

About COPT Defense Properties

COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.

The company’s portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.